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http:WHAT THIS PAPER ADDS
In many vascular units, ankle pressure, ankle brachial pressure, toe pressure (TP), and toe brachial index (TBI) are
essential measurements for clinical decision making and are routinely analysed in everyday practice. There are
no earlier studies comparing all four variables and patient outcome in a single study setting. Based on the
present observations it is suggested that non-invasive measurement of TP and TBI are associated with car-
diovascular and overall mortality, as well as amputation free survival of patients with peripheral artery disease.Objective/Background: Peripheral haemodynamic parameters are used to assess the presence and severity of
peripheral artery disease (PAD). The prognostic value of ankle brachial index (ABI) has been thoroughly
delineated. Nonetheless, the relative usefulness of ankle pressure (AP), ABI, toe pressure (TP), and toe brachial
index (TBI) in assessing patient outcome has not been investigated in a concurrent study setting. This study aimed
to resolve the association of all four non-invasive haemodynamic parameters in clinically symptomatic patients
with PAD with cardiovascular mortality, overall mortality, and amputation free survival (AFS).
Methods: In total, 732 symptomatic patients with PAD admitted to the Department of Vascular Surgery for
conventional angiography at Turku University Hospital, Turku, Finland, between January 2009 and August 2011
were reviewed retrospectively. Demographic factors, cardiovascular mortality, all-cause mortality, and above foot
level amputations were obtained and assessed in relation to AP, ABI, TP, and TBI by means of KaplaneMeier life
tables and a multivariate Cox regression model.
Results: The haemodynamic parameter that was associated with poor 36 month general outcome was TP <
30 mmHg. Univariate Cox regression analysis of stratified values showed that TP and TBI associated significantly
with mortality. In multivariate analysis both TP and TBI were associated with a significant risk of death. For TP <
30 mmHg and TBI < 0.25 the risk of cardiovascular mortality was hazard ratio [HR] 2.84, 95% confidence interval
[CI] 1.75e4.61 [p< .001]; HR 3.68, 95% CI 1.48e9.19 [p¼ .050], respectively; all-cause mortality (HR 2.05, 95%
CI 1.44e2.92 [p< .001]; HR 2.53, 95% CI 1.35e4.74 [p¼ .040], respectively); and amputation or death (HR 2.13,
95% CI 1.52e2.98 [p< .001]; HR 2.46, 95% CI 1.38e4.40 [p¼ .050], respectively)...
Conclusion: Among non-invasive haemodynamic measurements and pressure indices both TP and TBI appear to
be associated with cardiovascular and overall mortality and AFS for patients with PAD presenting symptoms of
the disease.
 2017 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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//dx.doi.org/10.1016/j.ejvs.2017.02.012cardiovascular events. Today, an estimated 200 million
people worldwide are affected by PAD, with the number
constantly increasing, owing not only to longer life expec-
tancy, but also to manifestation of the disease at a younger
age.1e3 Early detection of PAD and initiation of optimal
medical and conservative treatment is thus becoming
increasingly important.
Measurements of ankle and toe systolic pressures (AP
and TP, respectively) and their relation to that in the arm
(ankle brachial index [ABI] and toe brachial index [TBI]) have
Lower Limb Blood Pressure: Mortality and Amputation 697been widely applied to the initial assessment of peripheral
circulation. The diagnostic limitations of ABI have been
thoroughly addressed. Decreased ABI (< 0.9) has been
shown to be strongly associated with increased risk of
myocardial infarction and cardiovascular death.4,5 However,
the usefulness of ABI may be reduced in conditions such as
diabetes, chronic kidney disease, and advanced age, owing
to arterial stiffening and incompressibility of the leg arteries
at ankle level.6e8 Both low and high ABI among diabetic
patients correlate with increased risk of cardiovascular
mortality in a U-shaped fashion.8,9 Thus, arterial stiffening
may reduce both the diagnostic and prognostic value of ABI,
especially among diabetics.
As digital arteries are generally regarded as less suscep-
tible to vessel stiffness, the use of TP and TBI has been
recommended in order to overcome the influence of arte-
rial incompressibility.6,9 However, among diabetics the
diagnostic value of TBI has been questioned.10,11 The cor-
relation of low TP with increased mortality and decreased
amputation free survival (AFS) has been demonstrated in
patients with incompressible leg arteries.12,13
In addition to AP and ABI, TP is used in the widely
accepted TransAtlantic Inter-Society Consensus II (TASC II)
classification of limb ischaemia.14e17 Low TP appears to
serve as a prognostic marker for wound healing in PAD.14
Further risk stratification of patients with CLI based on
the severity of tissue loss, ischaemia, and foot infection
(WIfI) has recently been created by the Society for Vascular
Surgery Lower Extremity Guidelines Committee.18 Yet, not
every patient with haemodynamic criteria for severe
ischaemia, even according to WIfI, may require
revascularisation.13
Even today, data regarding means of identifying which
patients with PAD have the greatest risk of major cardio-
vascular events or amputation is limited. Non-invasive
measurement of haemodynamic parameters is feasible
and routinely carried out in vascular practice. However, the
overall relative prognostic value of AP, ABI, TP, and TBI re-
mains to be further elucidated. We have analysed the
relationship between these parameters and mid-term car-
diovascular and all-cause mortality, as well as AFS in
vascular surgical patients. To the authors’ knowledge, there
are few previous data comparing all four parameters in a




This retrospective study consisted of all consecutive
symptomatic patients with PAD admitted to the Depart-
ment of Vascular Surgery, Turku University Hospital, Turku,
Finland, for either diagnostic or therapeutic conventional
lower limb angiography (digital subtraction angiography
[DSA]) from 1 June 2009 to 31 August 2011. The aim was
to analyse the influence of peripheral pressures and
pressure indices on 36 month survival at the time of
clinical presentation with insufficient arterial circulation,before any revascularisation procedures. Although 887
patients were recruited, standardised peripheral pressure
measurements were available for only 732 patients. This is
a result of poor availability of vascular laboratory mea-
surements outside office hours. Patients were included
irrespective of their earlier PAD history. The study protocol
was approved by the local ethical committee of the Hos-
pital District of South-West Finland. Owing to the retro-
spective nature of this study, informed patient consent
was not required.
Vascular laboratory
Standardised non-invasive haemodynamic measurements
were carried out by experienced vascular technicians at
Turku University Hospital Vascular Laboratory. Measure-
ments were obtained with patients in a supine position
with feet at heart level, using a Nicolet VasoGuard (Nicolet
Vascular Inc. Madison, WI, USA) photoplethysmography
(PPG) device in all patients. When stable signals were ob-
tained, brachial, ankle, and digital cuffs were inflated until
disappearance of the PPG signal, typically up to 200 mmHg.
Brachial pressure, AP, and TP were determined by gradual
deflation of the cuffs to the moment of reappearance of a
pulsatile signal. Signals were later checked offline. TP was
preferentially measured from the great toe or, if it was
missing, from the nearest available toe. A mean of 3e5
measurements of TP was used for analysis. Either APs or
TPs were available for 732 patients prior to possible
revascularisation. AP and ABI were available for 720 pa-
tients, and TP and TBI for 717 patients. In 708 patients
both measurements were available. Measurements for the
clinically relevant limb were registered. When both limbs
were symptomatic, measurements for the limb with the
lowest TP were registered. Where TP was not available,
measurements for the limb with the lowest AP were
registered.
TP and TBI were not measurable in 15 patients with
previous forefoot amputations or severe tissue loss
involving the toes. AP was unavailable for 12 patients,
either owing to pain or reduced ability to cooperate. Pres-
sure indices for one patient were not available owing to
apparently incompressible arteries in both upper extrem-
ities with bilateral non-occluded cuff pressures of >
250 mmHg in the arms.
Data collection
Patient baseline characteristics at admission, which served
as the index date for follow-up, were retrospectively
collected from the hospital electronic database. Only In-
ternational Classification of Diseases (ICD) 10 coded di-
agnoses were registered. The following risk factors were
collected for analysis: coronary artery disease (CAD), cere-
brovascular disease (CVD), hypertension, active smoking,
diabetes, sleep apnea, chronic obstructive pulmonary dis-
ease (COPD), end stage renal disease (ESRD), dyslipidemia,
AP, ABI, TP, TBI, and serum creatinine level. Baseline medi-
cation including statins, clopidogrel, aspirin, warfarin, and
698 J.-E. Wickström et al.novel anticoagulants was registered from within electronic
patient files where reliably available. A reliable medication
history was unavailable for 51 patients (7.0%). Deaths
within the patient cohort were registered for the first 36
months, which was the cutoff point for follow-up. Later, in
2015, the causes of death were collected from the Finnish
centre for statistics, which has a 2 year delay in publishing
official mortality data. For the purposes of this study, causes
of death were categorized into cardiovascular and other.
Only major (above- ankle) amputations were registered.
For statistical analysis, peripheral pressures were pooled
into categories adapted from the TASC II recommendation.16
Categories for ankle pressures were < 50 mmHg, 50e
69 mmHg, and 70 mmHg, and indisputably incompressible
leg arteries with a pressure of> 250 mmHg were assigned to
category 4. TP data were pooled into three categories: 0eTable 1. Demographic data from the study cohort.
Cohort demographics Prevalence
(n¼ 732)














Note. Data are % unless otherwise indicated. CAD¼ coronary
artery disease; CVD¼ cerebrovascular disease; ESRD¼ end stage
renal disease; COPD¼ chronic obstructive pulmonary disease.
Table 2. Demographic data by defined toe pressure (TP) categories.
Cohort demographics < 30 mmHg (n¼ 232) 30
Mean SD age (y) 75 (11) 72





Sleep apnoea 3,4 8
ESRD 8 13
Dyslipidemia 34 35





Note. Data are % unless otherwise indicated. An even distribution of mo
significantly low in TP category < 30 mmHg, and the use of statins w
significance was tested using a chi-square test for categorical varia
disease; CVD¼ cerebrovascular disease; ESRD¼ end stage renal disea29mmHg, 30e49mmHg, and 50mmHg. Categories for ABI
were chosen in accordance with their relationship to car-
diovascular events, as presented byMehler et al. as follows:19
< 0.25, 0.25e0.49, 0.50e0.74, 0.75e0.89, 0.90e1.30, and>
1.30. Categories for TBI were as follows: < 0.25, 0.25e0.49,
and 0.5. Cardiovascular deaths were collected according to
the Finnish centre for statistics’ classification. All cardiovas-
cular causes of deathwere included namely ICD-10 diagnoses
I00-I42.5 and I42.7-I99Statistical analyses
All statistical analyses were performed using SPSS version
22 (IBM, Armonk, NY, USA). Group specific baseline char-
acteristics are presented as percentages, and continuous
variables as mean SD. Group variables were compared
using Pearson’s chi-square test. For continuous variables a
ShapiroeWilk test was run to test the normality of the
variables. Variables were then compared by analysis of
variance, as the continuous variables in each group were
normally distributed.
KaplaneMeier survival curves representing cumulative
survival were constructed for the study groups based on
haemodynamic measurements as described above. Survival
curves for each variable in defined groups were compared
using Wilcoxon statistics. For Cox regression analysis, a uni-
variate analysis using the Cox model was first performed, then
the variables with a p value < .15 in the univariate analysis
were added to themodel. All study outcomesdcardiovascular
and overall mortality and AFdwere analysed separately. For
multivariate Cox regression analysis, haemodynamicmeasures
resulting in p values< .15 on all outcomes, cardiovascular, and
overall mortality and AFS were included. The highest group
was selected as reference for categorical pressures and
indices. To avoid false positive observations the p values were
Bonferroni adjusted if they include multiple exposures. A p
value < .05 was considered statistically significant.e49 mmHg (n¼ 227)  50 mmHg
(n¼ 258)
p














st risk factors was detected. The prevalence of smoking history was
as significantly more common in higher TP categories. Statistical
bles and t test for continuous variables. CAD¼ coronary artery
se; COPD¼ chronic obstructive pulmonary disease.
Lower Limb Blood Pressure: Mortality and Amputation 699RESULTS
Patient characteristics, pressure indices, and peripheral
pressure categories
Forty-two percent of the study population were women and
the mean age was 72 11 years. General patient charac-
teristics are presented in Table 1. Category specific patient
characteristics are shown in Table S1 for AP and Table S2 for
TP (see Supplementary Material) (see Table 2).TP and patient outcome
The cardiovascular survival within TP groups was as follows:
(i) TP < 30 mmHg: 29.4 months (SE 0.85; 95% confidence
interval [CI] 27.7e31.0); (ii) TP 30e49 mmHg: 32.8 months
(SE 0.67; 95% CI 31.5e34.1); (iii) TP  50 mmHg: 34.9
months (SE 0.45; 95% CI 34.1e35.8). Cardiovascular mor-
tality was significantly increased in the group of patients
with TP 0e29 mmHg compared with TP 30e49 mmHg
(p¼ .001) and TP  50 mmHg (p< .001) (Fig. 1A). For
overall survival (OS) and AFS, KaplaneMeier curves are
presented in Figs 2(A) and 3(A), respectively.AP and patient outcome
The cardiovascular survival within AP groups was as follows:
(i) AP < 50 mmHg: 28.7 months (SE 1.5; 95% CI 25.8e31.7);Figure 1. KaplaneMeier curves demonstrating mid-term (36 month) c
grouping as follows: < 30 mmHg, 30e49 mmHg, and > 50 mmHg. (B)
70 mmHg, and > 250 mmHg. (C) Toe brachial index (TBI) grouping as fo
grouping as follows: < 0.25, 0.25e0.49, 0.50e0.74, 0.75e0.89, 0.90e1
at risk entering interval at each group for 0, 6, 12, 18, 24, 30, and 36(ii) TP 50e69 mmHg: 32.6 months (SE 0.81; 95% CI 31.0e
34.2); (iii) TP  70e250 mmHg: 33.4 months (SE 0.45; 95%
CI 32.5e34.3); and (iv) > 250 mmHg 30.2 months (SE 1.6;
95% CI 27.0e33.3). Patients with AP  70 mmHg had
significantly less cardiovascular mortality than those with an
AP < 50 mmHg (p< .001) or incompressible leg arteries
with an AP > 250 mmHg (p< .015) (Fig. 1B). Corresponding
KaplaneMeier curves for OS and AFS are presented in Figs
2(B) and 3(B), respectively.TBI and patient outcome
Cardiovascular survival within the TBI groups was as fol-
lows: (i) TBI < 0.25: 30.3 months (SE 0.71; 95% CI 28.9e
31.7); (ii) TBI 0.25e0.49: 33.5 months (SE 0.52; 95% CI
32.5e34.6); and (iii) TBI  0.50: 35.9 months (SE 0.52; 95%
CI 34.9e36.9). Cardiovascular mortality in the group with a
TBI < 0.25 was significantly increased compared with other
groups (TBI 0.25e0.49: p< .001; TBI  0.50: p< .001
[Fig. 1C]). KaplaneMeier curves for OS and AFS are pre-
sented in Figs 2(C) and 3(C), respectively.ABI and patient outcome
Cardiovascular survival within the ABI groups was as fol-
lows: (i) ABI < 0.25: 27.5 months (SE 1.9; 95% CI 23.7e
31.2); (ii) ABI 0.25e0.49: 32.9 months (SE 0.70; 95% CIardiovascular mortality among the study cohort. (A) Toe pressure
Ankle pressure grouping as follows: < 50 mmHg, 50e69 mmHg, 
llows: < 0.25, 0.25e0.49, and  0.50. (D) Ankle brachial index (ABI)
.30, and > 1.30. Lower part of figure indicates number of patients
months.
Figure 2. KaplaneMeier curves demonstrating mid-term (36 month) overall mortality. (A) Toe pressure grouping as follows: < 30 mmHg,
30e49 mmHg, and > 50 mmHg. (B) Ankle pressure grouping as follows: < 50 mmHg, 50e69 mmHg,  70 mmHg, and > 250 mmHg. (C)
Toe brachial index (TBI) grouping as follows: < 0.25, 0.25e0.49, and  0.50. (D) Ankle brachial index (ABI) grouping as follows: < 0.25,
0.25e0.49, 0.50e0.74, 0.75e0.89, 0.90e1.30, and > 1.30. Lower part of figure indicates number of patients at risk entering interval at
each group for 0, 6, 12, 18, 24, 30, and 36 months.
700 J.-E. Wickström et al.31.6e34.3); (iii) ABI 0.50e0.75: 33.4 months (SE 0.58; 95%
CI 32.3e34.6); (iv) ABI 0.75e0.89: 34.3 months (SE 0.97;
95% CI 32.4e36.2); (v) ABI 0.90e1.30; 31.4 months (SE 1.5;
95% CI 28.5e34.4); and (vi) ABI > 1.30: 29.3 months (SE
1.6; 95% CI 26.3e32.4). Cardiovascular deaths were most
prevalent in the group of patients with an ABI < 0.25, and
the difference was significant compared with the groups
with an ABI 0.25e0.49 (p¼ .007), 0.50e0.75 (p< .001),
and 0.75e0.89 (p¼ .004) (Fig. 1D). For OS and AFS Kaplane
Meier curves are presented in Figs 2(D) and 3(D),
respectively.Cox regression analysis
For the multivariate Cox regression analysis, risk factors
were selected according to the Cox univariate analysis. For
all three outcomes, age, CAD, CVD, hypertension, diabetes,
ESRD, dyslipidemia, and smoking history were added to the
model based on p< .15. For analysis of cardiovascular
mortality, COPD was also added to the model owing to
p< .15.
Including TP in multivariate analysis showed that for all
study endpoints (cardiovascular and overall mortality and
amputation or death) TP < 30 mmHg (vs. TP  50 mmHg)
was associated with a significant risk (hazards ratio [HR]2.84, 95% CI 4.61e1.75 [p< .001]; HR 2.05, 95% CI 2.92e
1.44 [p< .001]; HR 2.13, 95% CI 2.98e1.52 [p< .001],
respectively) (see Table 3). For all selected risk factors and
study endpoints, and results of the Cox models see
Tables S2eS4 (Supplementary Material).
Multivariate analysis, including TBI, showed that for all
three study endpoints (cardiovascular and overall mortality
and amputation or death) TBI < 0.25 (vs. TBI  0.50) was
associated with a significant risk (HR 3.68, 95% CI 1.5e9.2
[p¼ .05]; HR 2.53, 95% CI 1.3e4.7 [p¼ .04]; HR 2.46, 95%
CI 1.4e4.4 [p¼ .02], respectively) (see Table 4). For all
selected risk factors and study endpoints, and the results of
the Cox models see Tables S2eS4 (Supplementary
Material).
Multivariate analysis did not show any significant risk
associations for the AP and ABI groups. For all risk factors
and study endpoints, and results of the Cox models, see
Tables S2eS4 (Supplementary Material).
DISCUSSION
The association of an ABI < 0.9 with an increased rate of
cardiovascular events and overall mortality has been known
for decades.20,21 The relationship is U-shaped owing to
incompressible leg arteries affecting the values, especially
among diabetics.8,9 In a series of patients with PAD, with
Figure 3. KaplaneMeier curves demonstrating mid-term (36 month) amputation free survival. (A) Toe pressure grouping as follows: <
30 mmHg, 30e49 mmHg, and > 50 mmHg. (B) Ankle pressure grouping as follows: < 50 mmHg, 50e69 mmHg,  70 mmHg, and >
250 mmHg. (C) Toe brachial index (TBI) grouping as follows: < 0.25, 0.25e0.49, and  0.50. (D) Ankle brachial index (ABI) grouping as
follows: < 0.25, 0.25e0.49, 0.50e0.74, 0.75e0.89, 0.90e1.30, and > 1.30. Lower part of figure indicates number of patients at risk
entering interval at each group for 0, 6, 12, 18, 24, 30, and 36 months.
Table 3. The result of multivariate analysis on the association
between toe pressure (TP) and cardiovascular mortality, overall
mortality, and amputation free survival (AFS).
HR 95% CI p
Cardiovascular mortality
TP < 30 mmHg 2.84 1.75e4.61 < .001
TP 30e49 mmHg 1.61 0.96e2.70 .720
TP  50 mmHg Reference
Overall mortality
TP < 30 mmHg 2.05 1.44e2.92 < .001
TP 30e49 mmHg 1.33 0.91e1.94 1.00
TP  50 mmHg Reference
AFS
TP < 30 mmHg 2.13 1.52e2.98 < .001
TP 30e49 mmHg 1.29 0.90e1.85 1.00
TP  50 mmHg Reference
Note. The risk factors were selected for the model according to Cox
univariate analysis with a p value < .15 as follows: age, coronary
artery disease, cerebrovascular disease, diabetes, hypertension,
end stage renal disease, dyslipidemia and smoking history
(overall mortality and AFS), and additionally chronic obstructive
pulmonary disease for cardiovascular outcome analysis.
HR¼ hazard ratio; CI¼ confidence interval.
Table 4. Results of multivariate analysis on the association
between toe brachial index (TBI) and cardiovascular mortality,
overall mortality, and amputation or death.
HR 95% CI p
Cardiovascular mortality
TBI < 0.25 3.68 1.48e9.19 .05
TBI 0.25e0.49 2.11 0.83e5.35 1.00
TBI  0.50 Reference
Overall mortality
TBI < 0.25 2.53 1.35v4.74 .04
TBI 0.25e0.49 1.94 1.03e3.64 .410
TBI  0.50 Reference
Amputation or death
TBI < 0.25 2.47 1.38e4.40 .050
TBI 0.25e0.49 1.70 0.94e3.05 1.00
TBI  0.50 Reference
Note. The risk factors were selected for the model according to Cox
univariate analysis with a p value < .15 as follows: age, coronary
artery disease, cerebrovascular disease, diabetes, hypertension,
end stage renal disease, dyslipidemia, and smoking history
(overall mortality and amputation or death) and additionally
chronic obstructive pulmonary disease for cardiovascular
outcome analysis.
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rates in both groups in a similar fashion.22 Studies on the
association between TP and patient outcome are scarce. A
few studies have demonstrated the predictive effect of TBI
on cardiovascular mortality and morbidity, irrespective of
the diabetic status of the patient.9,23 In this study, which
included > 700 patients with TP measurements, a linear
correlation between TP and TBI with cardiovascular and
overall mortality, as well as AFS, was shown. Furthermore,
in line with earlier studies, a U-shaped correlation between
ABI and all three investigated endpoints was observed. The
data emphasise the pitfalls in relying solely on ABI when
assessing patients with PAD and their prognosis. In the
present study population 41% were diabetic and 10% had
incompressible leg arteries with an ABI > 1.3. Moreover, it
is conceivable that APs in some limbs may be falsely high
owing to undetected partial vessel wall incompressibility.
The role of TBI in diagnosing PAD is indefinable, and
criteria for stratifying normal versus pathological TBI remain
ambiguous. Guidelines recommend < 0.70 as a cutoff, but
this is not entirely evidence based.24 There are no data
confirming the utility of TBI in early detection of PAD among
diabetics. In a recent Dutch study, which included patients
with an ABI  1.4, diabetes appeared to falsify ABI and TBI
in a similar fashion.11 It may be worth noting that, in the
present study, 7% of patients with a TBI  0.25 had a TP <
30 mmHg. Nonetheless, an increased cardiovascular mor-
tality and poor OS in the group with a TBI < 0.25 was
observed. Between the defined categories, the increased
risk was step wise. This result is in line with a previous study
by Hyun et al.,9 although their approach was different. A
normal TBI value was a rarity in the present study, with the
indices of only eight patients exceeding 0.75.
The risk of amputation has been demonstrated to be
associated with low TP values.25e27 According to the pre-
sent data, TP has a strong association with mid-term car-
diovascular and all-cause mortality, as well as AFS. All-cause
mortality has previously been linked to low TP in a relatively
small cohort of 53 patients and 76 limbs, with similar results
to the data presented here.26 The current study is an
analysis of 732 patients. TP values fulfilling the criteria for
CLI were observed in 233 patients (TP < 30 mmHg). The
findings further support the notion that TP may serve as a
powerful, non-invasive tool for detecting patients at highest
risk of death and therefore being in need of optimal medical
prevention of major cardiovascular events, death, or major
amputation. The use of TP as a single prognostic or diag-
nostic tool for the evaluation of patients at risk of cardio-
vascular events is a tempting option, as it is a simple, non-
invasive method available even in a general practitioner’s
office.24 It may also provide a tool superior to ABI for
screening high risk patients at diabetes outpatient clinics,
owing to linear risk stratification.
In the present study, TP measurements were categorized
according to criteria for CLI.16,17,28 It is generally accepted
that CLI is associated with poor patient outcome.20,29 Ac-
cording to the present data, a TP < 50 mmHg, and espe-
cially a TP < 30 mmHg, is significantly associated with poorpatient outcome, further supporting the malignant nature
of CLI.
Poor exercise capacity has been suggested to be the
strongest predictor of mortality among patients with PAD,
even compared with all earlier known major risk factors for
PAD and CAD.30,31 Non-invasive limb pressure measure-
ments were not assessed by these analyses. The prognostic
value of combined exercise capacity and distal non-invasive
pressure measurements on mortality is a tempting target
for further studies.
When considering generalisation of the present results, it
should be kept in mind that all the patients had symp-
tomatic PAD and were referred for DSA by a vascular
specialist. Thus, the cohort did not include individuals who
did not fulfill the criteria for invasive treatment and are
preferentially taken care of by primary healthcare. However,
the study population was wide and heterogeneous, as it
contained patients irrespective of diabetic status or PAD
history. Owing to this, the results obtained should be widely
applicable to everyday vascular practice.
CONCLUSIONS
Earlier studies have also demonstrated a U-shaped prog-
nostic value of ABI on patient survival. In addition, ABI has
been shown to be a potent non-invasive tool in PAD
screening. In many vascular units, AP, ABI, TP, and TBI are
essential measurements for clinical decision making and are
routinely analysed in everyday practice. There are no earlier
studies comparing all four variables and patient outcome in
a single study setting. Based on the present observations, it
is suggested that non-invasive measurement of TP and TBI
are predictive of cardiovascular mortality, overall mortality,
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